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This manuscript is written in dedication to Emeritus Professor 
Beighton, whom I, Collet Dandara, met in 2009. Professor 
Beighton has been an inspiration from whom I have always sought 
advice. We have co-authored two publications together and I have 
learnt a great deal from him, for which I am eternally grateful and 
indebted to him.
Background
Apolipoprotein B mRNA-editing catalytic polypeptide like-3G 
(APOBEC3G) deaminates cytidine (C) to uracil (U) in the negative 
strand of HIV genome and subsequently guanine (G) to adenine 
(A) on the positive strand leading to G to A hypermutation.[1] 
Hypermutated HIV genome is prone to degradation. Hypermutation 
also introduces multiple stop codons in the HIV reading frame, 
reducing viral fitness.[2] A hypermutated HIV-1 variant has reduced 
transmission fitness. HIV counteracts antiviral activity of APOBEC3G 
through the viral infectivity factor (Vif) targeting APOBEC3G for 
degradation.[3] APOBEC3G antiviral activity presents a potential 
therapeutic target against HIV. However, the role of polymorphisms 
in APOBEC3G on the risk of HIV infection and disease progression 
remains contested. 
A study by An et al.[4] reported seven single nucleotide polymorphisms 
(SNPs) in APOBEC3G, three in the promoter, and two each in exons 
and introns.[4] APOBEC3G c.557A>G (p.H186R) in exon 4 is the 
most studied SNP and APOBEC3G c.557G/G genotype and c.557G 
allele have been linked to accelerated HIV disease progression 
compared with other c.557A carrying genotypes and the c.557A 
allele in adults. [4,5] In paediatric populations, the c.557G/G genotype 
has been linked to faster decline in CD4 T-cell count[6] and greater 
tendency to central nervous system impairment when compared with 
the c.557A/A and c.557 A/G genotypes.[7] However, the influence of 
APOBEC3G genetic polymorphisms in vertical transmission of HIV 
remains unknown. 
A study measuring APOBEC3G mRNA levels in human cells 
from different groups of HIV-positive people reported that mRNA 
abundance followed the order: long-term non-progressors>HIV 
uninfected>progressors, with the mRNA levels correlating 
positively with CD4 T-cell counts and inversely with viral loads.[8] 
Kikuchi and colleagues[9] reaffirmed the importance of APOBEC3G 
activity in HIV with a demonstration of attenuation of anti-
APOBEC3G activity of HIV-1 Vif protein in elite HIV controllers. 
These observations suggest that increased APOBEC3G expression 
may slow progression of disease in HIV infected individuals. 
Literature on APOBEC3G genetic polymorphisms is available for 
most world populations, but with very little coverage of African 
populations; yet, these African populations possess the most genetic 
diversity; thus findings from other populations may not always 
explain what is found in Africans. This study, therefore, describes 
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polymorphisms in APOBEC3G and their role in predicting risk of 
HIV infection in children by evaluating distribution of APOBEC3G 
variants in three groups of children: 
• Children born to HIV-infected mother and born infected (exposed 
and infected, EI);
• Children born to HIV-infected mothers and born uninfected 
(exposed but uninfected, EUI); and
• Children born to uninfected mothers (unexposed, uninfected, 
UEUI). Frequencies of APOBEC3G variants were also compared 
with other African and world populations.
Methods 
Study participants
A cross-sectional study of APOBEC3G gene polymorphisms and 
their possible association with HIV infection in HIV-exposed 
children was conducted. Participants were recruited from the Better 
Health for the African Mother and Child (BHAMC) cohort, a 
longitudinal study of mother-child pairs followed up between 2002 
and 2012, as described elsewhere.[10] In summary, the participants 
were 104 unrelated children aged 7 to 9 years, of bantu African 
origin. These included 32 children perinatally infected with HIV 
(EI) who were available in the cohort at the time of collection, and 
72 healthy HIV-uninfected children comprising 36 exposed to HIV 
in utero but not infected (EU) and 36 unexposed and uninfected 
(UEUI). The EU and UEUI groups were combined to form the 
controls. Written informed consent was obtained from each child’s 
parent or legal guardian before the samples were collected. The 
study received ethics approval from the Medical Research Council 
of Zimbabwe and the University of Cape Town Faculty of Health 
Sciences Research Ethics Committee. 
Genotyping of APOBEC3G gene variants
Genomic DNA was extracted from blood samples using the 
Nucleospin Blood L kit (Macherey-Nagel, Germany) according to 
the manufacturer’s instructions. Five SNPs were investigated in the 
APOBEC3G gene; two in the promoter region (g.-571G>C, rs5757463 
and g.-90C>G, rs5750743), one in exon 4 (c.557A>G, rs8177832) 
and two in introns (c.467-85T>C, rs3736685 and c.582-162C>G, 
rs2294367).
Variation at c.557A>G and g.-90C>G were genotyped using 
polymerase chain reaction-restriction fragment polymorphism 
(PCR-RFLP) whilst SNaPshot was used to genotype the 
remaining three. The APOBEC3G c.557A>G polymorphism was 
determined using a method previously described elsewhere but 
with minor modifications.[4] A 409bp DNA fragment flanking 
the c.557A>G site was generated from a PCR reaction. The 
PCR product was subsequently digested using 2 U of HhaI 
(Fermentas, Canada) restriction enzyme. The G allele resulted 
in the generation of three fragments: 194bp, 145bp and 70bp, 
while the A allele resulted in only two bands: 339bp and 70bp. 
Genotyping for APOBEC3G g.-90C>G involved amplification 
of a 355bp fragment flanking the SNP in a PCR reaction and 
digestion of the PCR products with 5 U of AvaI (Fermentas, 
Canada) to determine the allelic variants. The C variant resulted 
in two fragments, 259bp and 96bp whilst the G variant was 
undigested, presenting as a 355bp fragment. 
The PCR based primer extension (SNaPshot) method was used 
to genotype three SNPs in the APOBEC3G gene; g.-571G>C, c.467-
85T>C and c.582-162C>G. Three sets of sense and antisense primer 
pairs were designed to amplify three DNA fragments flanking 
SNPs: rs5757463G>C (Forward-GCAAATGCATCCCT TGT-
GTA, Reverse-CCTCCTCTCCACCATCAAGA), rs3736685T>C 
(Forward-TAC CCTGACCATCTTTGTTGC, Reverse-ACA-
CGAACTTGCTCCAACAGT) and rs2294367C>G (Forward-GTG-
AGGCCAGGGAAGAAGA, Reverse-TGA AAG TGA ATG TGG-
GTG GA), respectively. Genotyping of APOBEC3G g.-571G>C and 
c.582-162C>G variants was done simultaneously in a multiplex 
SNaPshot reaction. The reaction contained g.-571G>C primer 
(AATTTGTAGGTCACCACGCCATAGGAACACACTACCA) 
and c.582-162C>G primer (TGGCACTGACTGTAACTAGTATC). 
To determine the g.-571G>C and c.582-162 alleles, the SNaPshot 
products were analysed through capillary electrophoresis. Unlike 
g.-571G>C and c.582-162C>G SNPs that were genotyped in a 
multiplex SNaPshot, c.467-85T>C variants were determined in a 
singleplex SNaPshot, using 20 pmol of the primer (ACATCCCTTAG
AATCTTGTCAGAAGAGGTTCCCACT TAC TTG CTA).
Statistical analysis
Genotype and allele frequencies were calculated using Stata version 
11.2 (StataCorp LP, USA) and/or SHEsisPlus online version. [11] 
Hardy Weinberg Equilibrium (HWE) was tested using χ2 or Fisher’s 
exact test with one degree of freedom. Chi-squared and Fisher’s 
exact tests were used, where appropriate, to test homogeneity in 
alleles and genotypes among the participant groups. p<0.05 was 
considered statistically significant for all comparisons. Pairwise 
linkage disequilibrium (LD) analyses between APOBEC3G SNPs were 
carried out using SHEsisPlus and haplotypes were inferred using the 
expected maximisation algorithm. During inference of haplotypes, 
each chromosome of a homologous pair was considered individually, 
giving a total of two times the number (2n) of individuals included 
in the analysis.
Table 1. Demographic and clinical characteristics of study 
participants
Characteristics
HIV EI, 
n=32
HIV EU and UEUI, 
n=72 p-value
Age (years) 0.28
Mean 8.22 8.43
SD 0.57 0.55
Range 7.25 - 9.08 7.50 – 9.08
Height (cm) 0.03
Mean 117.11 120.37
SD 6.22 6.00
Range 109 - 131 108 - 134
Weight (kg) 0.005
Mean 20.31 22.35
SD 1.99 3.01
Range 17 - 34 15 - 31
Head 
circumference (cm)
0.48
Mean 51.14 51.37
SD 1.57 1.20
Range 49 - 54 48 - 54
Sex    
Female, n (%) 19 (59) 36 (50) 0.37
Male, n (%) 13 (41) 36 (50)
SD = standard deviation; HIV EI = HIV exposed and infected; HIV EU = HIV exposed but 
uninfected; HIV UEUI = HIV unexposed and uninfected.
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Results
Demographic characteristics and association of 
APOBEC3G polymorphisms with HIV infection
Demographic characteristics of participants are described elsewhere[10] 
and are summarised in Table 1. Table 2 shows distribution of 
APOBEC3G variants in EI and EU children and the measures of 
association with HIV status. The APOBEC3G c.557G/G (p.186R) 
genotype occurred more frequently in EI children (59%) compared 
with EU children (47%) but the difference was not statistically 
significant. None of the APOBEC3G variants investigated were 
individually associated with risk of HIV infection. Thus, haplotype 
analysis was carried out to evaluate effects of co-inheritance of 
variants on risk of HIV infection.
Haplotypes in APOBEC3G gene with respect to g.-571G>C, 
g.-90C>G, c.467-85T>C, c.557A>G and c.582-162C>G SNPs were 
inferred using SHEsisPlus online software. Twenty-nine HIV-
infected and 64 HIV-uninfected individuals were successfully 
genotyped and included in haplotype and LD determination. 
Haplotype frequencies were compared between the HIV-infected 
children and HIV-uninfected. Haplotypes with frequencies less 
than 0.03 were excluded from analysis. Table 3 shows the haplotypes 
observed in HIV-infected and uninfected groups. None of the six 
haplotypes observed in the population was associated with risk of 
HIV infection in the children. APOBEC3G SNPs were generally in 
strong LD with each other except two pairs (c.557A>G and c.582-
162G, D’=0.36; c.582-162C>G and c.467-85T>C, D’=0.38).
Baseline allele frequencies and their comparison with 
other populations
We report frequencies for minor alleles in the HIV-uninfected 
(EU+UEUI) Zimbabwean population: APOBEC3G c.557G (40%), 
APOBEC3G g.-90C (32%), APOBEC3G g.-571C (12%), APOBEC3G 
c.467-85C (42%), and APOBEC3G c.582-162G (6%) (Table 4). To our 
knowledge, these variants are being reported for the first time in the 
Zimbabwean population. All SNPs conformed to the HWE in the 
HIV uninfected. Frequencies of variants in the current study were 
compared with other populations published on HapMap and National 
Center for Biotechnology Information (NCBI) dbSNP databases 
(Table 2), which include the Yoruba of Ibadan, Nigeria (YRI), African 
ancestry in southwest USA (ASW), Luhya in Webuye, Kenya (LWK), 
Maasai in Kinyawa, Kenya (MKK), Han Chinese in Beijing (HCB) 
and Utah residents with northern and western European ancestry 
(CEU). Frequencies of minor alleles in this group closely resembled 
those of YRI, ASW and LWK populations. APOBEC3G c.467-85C 
frequency was statistically significantly different when compared to 
the ASW population (42% v. 11%). The MKK genetic profile seemed 
to drift much more from the Zimbabwean group compared with other 
populations of African origin (YRI, LWK and ASW). Forty percent 
(n=2/5) of the SNPs showed significant differences between the 
Zimbabwean and MKK group. Asian and Caucasian populations (HCB 
and CEU, respectively) were largely different from the Zimbabwean 
population.
Discussion
This study describes genetic variation at five APOBEC3G loci and its 
association with HIV infection in Zimbabwean children born to HIV-
infected mothers. The frequency of 40% for the c.557G allele in the 
Zimbabwean population is slightly higher than that observed among 
black South Africans (30%)[4] and African Americans (37%)[5] but much 
higher than observed in Caucasians (<5%)[4] and Asians (0%). The 
APOBEC3G c.557A>G polymorphism results in a significant functional 
effect due to the histidine to arginine (p.H186R) that alters APOBEC3G 
Table 2. Frequency and distribution of APOBEC3G genotypes and their association with HIV status
Genotypes
HIV EI, n 
(freq)* HIV EU, n (freq)
HIV UEUI, n 
(freq) OR (95% CI)
p-value
EI v. EU
†A3G c.557A>G (rs8177832) N=32 N=36 N=36 - -
557A/A 9 (0.28) 12 (0.33) 15 (0.42) 1.00 -
557A/G 19 (0.59) 17 (0.47) 16 (0.44) 1.63 (0.56 - 4.70) 0.32
557G/G 4 (0.13) 7 (0.19) 5 (0.14) 0.59 (0.11 - 2.66) 0.44
A3G g.-90C>G (rs5750743) N=32 N=36 N=36 - -
-90G/G 16 (0.50) 17 (0.47) 16 (0.44) 1.00 -
-90C/G 14 (0.42) 17 (0.47) 15 (0.42) 0.87 (0.30 - 2.52) 0.77
-90C/C 2 (0.06) 2 (0.06) 5 (0.14) 1.13 (0.08 - 16.50) 0.90
A3G c.467-85T>C (rs3736685) N=32 N=36 N=36 - -
c.467-85T/T 9 (0.27) 13 (0.36) 16 (0.44) 1.00 -
c.467-85T/C 19 (0.61) 16 (0.44) 15 (0.42) 1.92 (0.67 - 5.61) 0.18
c.467-85C/C 4 (0.12) 7 (0.19) 5 (0.14) 0.57 (0.11 - 2.56) 0.41
A3G c.582-162C>G (rs2294367) N=31 N=32 N=34 - -
582-162C/C 29 (0.94) 30 (0.94) 29 (0.85) 1.00 -
582-162C/G 2 (0.06) 1 (0.03) 5 (0.15) 2.07 (0.10 - 126) 0.55
582-162G/G 0 (0.00) 1 (0.03) 0 (0.00) - 0.32
A3G g.-571G>C (rs5757463) N=30 N=31 N=36 - -
-571G/G 23 (0.77) 28 (0.90) 23 (0.64) 1.00 -
-571G/C 7 (0.23) 3 (0.10) 13 (0.36) 2.84 (0.56 - 18.63) 0.15
freq = frequency; OR = odds ratio; CI = confidence interval.
* Frequencies of genotypes were compared between EI group and EU group using the χ2 test.
†A3G-APOBEC3G.
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catalytic activity. The c.557G (p.186R) variant 
leads to poor protein assembly which 
reduces APOBEC3G’s catalytic function.[12] 
In addition to the possible effects of p.H186R 
amino acid alteration, APOBEC3G activity is 
determined by amount of enzyme available 
in circulation.[8] Inter-individual variation 
in circulating APOBEC3G may be a result 
of polymorphism in the gene’s promoter 
and other regulatory sequences including 
those at exon-intron junctions or used by 
spliceosomes. 
There is limited information on the 
frequency and distribution of APOBEC3G 
alleles in different populations. The 
frequency of the g.-90C allele in our study 
is lower than among the YRI (32% v. 
44%) but higher than among Caucasians 
(4%). The distribution of APOBEC3G 
c.467-85C allele frequency was also 
comparable between Zimbabweans 
(42%) and YRI (48%) but higher than 
that observed among Caucasians (4%) 
and Asians (5%). Frequencies of g.-571C 
and c.467-85C alleles were generally 
higher among Africans compared with 
Caucasians. Variant c.582-162G allele 
was more frequent among Caucasians 
(58%) and Asians (66%) compared with 
Zimbabweans (6%) and YRI (4%). The 
distribution of APOBEC3G alleles c.557G, 
g.-90C, c.467-85C and c.582-162G in 
the world mirrors distribution of HIV 
cases, where the highest prevalence is 
in sub-Saharan Africa where the highest 
number of HIV-infected people are found, 
compared with Europe and Asia. This 
suggests that APOBEC3G genetic variation 
may be contributing to the differences in 
susceptibility to HIV infection observed in 
different world populations. This supports 
findings by Skelton et al.[13] reporting 
on differential distribution of BST-2 
variants, which also mirrors HIV infection 
prevalence in Africa.[13] 
Despite the relationship between 
APOBEC3G variants and HIV prevalence in 
different populations, analysis of individual 
APOBEC3G SNPs may not be a good 
predictor of risk of HIV infection. Our 
findings support observations by An et al.[4] 
who, in a multicentre study involving highly 
exposed seronegative and HIV-seropositive 
individuals, did not observe any association 
between APOBEC3G variants and HIV 
status. However, the c.581+68T allele of a 
c.581+68C>T SNP (rs17496018) in exon 
4 of the APOBEC3G gene, which did not 
form part of this study, was associated with 
increased risk of HIV transmission.[6] These 
observations on APOBEC3G gene variation 
suggest that individual allelic variants 
may fail to show any effect on their own. 
However, their collective contribution to 
gene expression or overall protein structure 
may be important, as we have shown with 
other genes.[10,13-15]
In an effort to understand the combi-
national effect of APOBEC3G polymorphism 
on HIV transmission haplotype, frequencies 
were compared between HIV-infected 
and uninfected groups of children. LD 
was generally strong between pairs of the 
APOBEC3G SNPs studied in the population. 
This conforms to studies in Argentinians, 
Caucasians and African Americans, where 
all five SNPs investigated as part of this 
study have been reported to be in strong 
LD.[4] This implies a higher likelihood of 
co-inheritance of these APOBEC3G SNPs; 
thus, they may collectively influence risk 
of HIV infection and disease progression. 
Nonetheless, haplotype analysis of the SNPs 
failed to show association with risk of HIV 
infection further; hence, the collective role 
of APOBEC3G polymorphisms in HIV may 
be negligible.
The interpretation of the effect of 
APOBEC3G genetic variation in HIV infection 
and disease progression is difficult due to 
underlying genetic factors. Polymorphisms in 
other APOBEC genes such as APOBEC3F 
have also been linked with differential 
antiretroviral activity of their protein products. 
Given the complex network of interaction 
of proteins in the cytidine deamination 
antiviral pathway, determination of association 
between APOBEC3G genetic variants and HIV 
infection or disease progression would require 
large sample sizes and adjusting for other 
proteins involved, a motivation for genome-
wide association studies. Findings of this study 
may have been limited by the sample size, 
and unavailability of maternal virological and 
immunological information that may have 
influenced vertical transmission of HIV. 
Furthermore, the cross-sectional nature of the 
study makes it difficult to establish the causal 
relationship between APOBEC3G genotypes 
and HIV transmission. A longitudinal study 
using a bigger sample size and taking a pathway 
approach could be ideal.
Table 4. Comparison of allele frequencies (proportions) between the HIV-uninfected (EUI+UEUI) group and other populations 
published on HapMap and NCBI dbSNP databases*
Minor allele ZIM YRI LWK MKK ASW HCB CEU
g.-571C (rs5757463C) 0.12 0.04 NA NA NA NA 0.10
c.-90C (rs5757463C) 0.32 0.44 NA NA NA NA 0.32
c.467-85C (rs3736685C) 0.42 0.48 0.34 0.18† 0.31‡ 0.05† 0.031†
c.557G (rs8177832G) 0.40 0.48 0.34 0.18† 0.31 0.05† 0.031†
c.-162G (rs2294367G) 0.06 0.04 NA NA NA 0.66† 0.523†
NA = not available. 
* Frequencies of minor alleles for each polymorphism were compared between Zimbabweans and other populations using the χ2 test.† p<0.001. P-values are only shown where the difference from our study population was statistically significant.‡ p<0.05. P-values are only shown where the difference from our study population was statistically significant.
Table 3. Haplotype formation with respect to SNPs on the APOBEC3G gene and their 
association with HIV status
Haplotype HIV EI, n (freq) HIV EU, n (freq) Total, n p-value
GCTAC 13 (0.224) 15 (0.250) 28 0.741
GGTAC 12 (0.206) 13 (0.216) 25 0.896
CGTAC 5 (0.086) 3 (0.050) 8 0.486
GCCGC 3 (0.051) 2 (0.033) 5 0.676
GGCGC 20 (0.344) 23 (0.383) 43 0.663
GGTAG 1 (0.017) 3 (0.050) 4 0.618
Other 4 (0.069) 1 (0.016) 5 -
Total (2n) 58 60 118 -
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Conclusion
In conclusion, APOBEC3G gene is highly polymorphic in Zimbabweans, 
Africans and other world populations. Differences in frequencies of 
APOBEC3G variants between high HIV prevalence populations such 
as Africans and low-HIV populations such as Caucasians suggest 
the antiviral role of APOBEC3G enzyme may have been involved in 
shaping the distribution of viral diseases such as HIV. HIV infects 
human cells through a complex process that involves a multitude of 
most proteins, hence HIV disease is multifactorial. Thus, several host 
gene variants are likely to influence HIV pathogenesis; hence, their 
co-inheritance patterns present a strong candidate for determination 
of HIV infection and disease outcomes.
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